The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability

Sports Medicine Clinical Trial

Official title:

The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04051138
• Other study ID #: Voxx1
• Status: Completed
• Phase: N/A
• Start date: August 15, 2019
• Est. completion date: October 30, 2019

Study information

• Verified date: January 2021
• Source: ChampionsEdge, LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is designed to compare the effect of Voxx/eSmartr technology on common measures of sports vision performance including (Hand-Eye Coordination/Reaction time, visual concentration and basic visual functions of size detection and contrast sensitivity). The study will be a randomized, prospective, double-blind design in order to determine the effect of this technology on a subject's sports vision ability.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 30, 2019
• Est. primary completion date: October 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria.

• Female or Male age 18-45 years of age
• Exercises at least once a week by self-report
• Physically able to complete the HEC/RT test (e.g. no shoulder or arm discomfort or limitation Exclusion Criteria.
• Member of a vulnerable population
• Visual or physical condition which precludes performing the physical or visual testing (e.g. strabismus, double vision, shoulder or arm pain or injury)
• Previous training in hand-eye coordination/reaction time or visual concentration
• History of double vision or strabismus
• Insufficient vision to drive an automobile in NY State

Related Conditions & MeSH terms

• Sports Medicine
• Vision, Binocular

Intervention

Other:
• Voxx socks and sleeves
participants will be tested with a true device as well as with a placebo device

Locations

Country	Name	City	State
United States	SportsVisionNYC	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
ChampionsEdge, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CoreScore	A measure of visual function scored on a linear scale fro +5 to -5, more positive scores are better	1 day
Secondary	Hand-Eye Coordination/Reaction Time	A measure of how fast the subject reacts to a visual target with their hand, scored on milliseconds, faster the better	1 day
Secondary	Neurotracker score	A measure of how correctly the subject can track multiple objects, scored from 0 to 5 with higher score being better	1 day